Atnaujinkite slapukų nuostatas

El. knyga: Valuing Health for Regulatory Cost-Effectiveness Analysis

  • Formatas: 382 pages
  • Išleidimo metai: 28-Apr-2006
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309657006
  • Formatas: 382 pages
  • Išleidimo metai: 28-Apr-2006
  • Leidėjas: National Academies Press
  • Kalba: eng
  • ISBN-13: 9780309657006

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Promoting human health and safety by reducing exposures to risks and harms through regulatory interventions is among the most important responsibilities of the government. Such efforts encompass a wide array of activities in many different contexts: improving air and water quality; safeguarding the food supply; reducing the risk of injury on the job, in transportation, and from consumer products; and minimizing exposure to toxic chemicals. Estimating the magnitude of the expected health and longevity benefits and reductions in mortality, morbidity, and injury risks helps policy makers decide whether particular interventions merit the expected costs associated with achieving these benefits and inform their choices among alternative strategies. Valuing Health for Regulatory Cost-Effectiveness Analysis provides useful recommendations for how to measure health-related quality of- life impacts for diverse public health, safety, and environmental regulations. Public decision makers, regulatory analysts, scholars, and students in the field will find this an essential review text. It will become a standard reference for all government agencies and those consultants and contractors who support the work of regulatory programs.Table of Contents



Front Matter Executive Summary 1 Introduction 2 Characteristics of Major Regulations and Current Analytic Practices 3 Measures and Strategies for Obtaining Health Benefit Values for Regulatory Analysis 4 Beyond Ratios: Ethical and Nonquantifiable Aspects of Regulatory Decisions 5 Recommendations for Regulatory Cost-Effectiveness Analysis Appendix A Summary of Case Studies Appendix B Health Indexes Appendix C OMB Circular A-4 Appendix D Acronyms and Glossary Appendix E Biographical Sketches References Index
EXECUTIVE SUMMARY 1(14)
1 INTRODUCTION 15(26)
The Charge to the Committee,
16(3)
The Role of Economic Analysis in Regulatory Development,
19(7)
Benefit–Cost and Cost-Effectiveness Analysis,
26(14)
Organization of the Report,
40(1)
2 CHARACTERISTICS OF MAJOR REGULATIONS AND CURRENT ANALYTIC PRACTICES 41(26)
Types of Risk Regulations,
41(9)
Current Practices for Regulatory Analysis,
50(15)
Summary,
65(2)
3 MEASURES AND STRATEGIES FOR OBTAINING HEALTH BENEFIT VALUES FOR REGULATORY ANALYSIS 67(63)
Criteria for Selecting HALY Metrics for Regulatory CEA,
68(4)
Single-Dimension Measures of Health-Related Outcomes,
72(1)
Health-Adjusted Life Years,
73(19)
Sources of Health State Values for Regulatory Analysis,
92(31)
Research and Development of Metrics and Valuation Methodologies,
123(2)
Summary and Conclusions,
125(5)
4 BEYOND RATIOS: ETHICAL AND NONQUANTIFIABLE ASPECTS OF REGULATORY DECISIONS 130(29)
Ethical Assumptions in QALY-Based CEA,
132(8)
Ethical and Other Implications of Risks and of Interventions to Address Risks,
140(4)
Distributional Concerns about Risks and Regulatory Interventions,
144(11)
Improving Regulatory Decision Making,
155(2)
Conclusions,
157(2)
5 RECOMMENDATIONS FOR REGULATORY COST-EFFECTIVENESS ANALYSIS 159(34)
Recommendations,
161(27)
Summary,
188(5)
APPENDIXES
A Summary of Case Studies
193(52)
B Health Indexes
245(9)
The Quality of Well-Being Scale,
245(2)
The Health Utilities Index Mark 2,
247(2)
The Health Utilities Index Mark 3,
249(3)
The EuroQoL-5D,
252(1)
The SF-6D,
253(1)
The Functional Capacity Index,
254(4)
C OMB Circular A-4
258(58)
D Acronyms and Glossary
316(10)
E Biographical Sketches
326(9)
REFERENCES 335(16)
INDEX 351


Wilhelmine Miller, Lisa A. Robinson, and Robert S. Lawrence, Editors, Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation